Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 4
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean merrot t (108 results)?
Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.
Low JS, Vaqueirinho D, Mele F, Foglierini M, Jerak J, Perotti M, Jarrossay D, Jovic S, Perez L, Cacciatore R, Terrot T, Pellanda AF, Biggiogero M, Garzoni C, Ferrari P, Ceschi A, Lanzavecchia A, Sallusto F, Cassotta A. Low JS, et al. Among authors: terrot t. Science. 2021 Jun 18;372(6548):1336-1341. doi: 10.1126/science.abg8985. Epub 2021 May 18. Science. 2021. PMID: 34006597 Free PMC article.
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation.
Luciani M, Müller D, Vanetta C, Diteepeng T, von Eckardstein A, Aeschbacher S, Rodondi N, Moschovitis G, Reichlin T, Sinnecker T, Wuerfel J, Bonati LH, Saeedi Saravi SS, Chocano-Bedoya P, Coslovsky M, Camici GG, Lüscher TF, Kuehne M, Osswald S, Conen D, Beer JH; SWISS-AF Investigators. Luciani M, et al. Heart. 2023 Feb 14;109(5):396-404. doi: 10.1136/heartjnl-2022-321300. Heart. 2023. PMID: 36593094 Clinical Trial.
Long-term risk of adverse outcomes according to atrial fibrillation type.
Blum S, Aeschbacher S, Coslovsky M, Meyre PB, Reddiess P, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Müller R, Beer JH, Kobza R, Bonati LH, Moutzouri E, Rodondi N, Meyer-Zürn C, Kühne M, Sticherling C, Osswald S, Conen D; BEAT-AF and Swiss-AF investigators. Blum S, et al. Sci Rep. 2022 Feb 9;12(1):2208. doi: 10.1038/s41598-022-05688-9. Sci Rep. 2022. PMID: 35140237 Free PMC article.
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.
Marzi R, Bassi J, Silacci-Fregni C, Bartha I, Muoio F, Culap K, Sprugasci N, Lombardo G, Saliba C, Cameroni E, Cassotta A, Low JS, Walls AC, McCallum M, Tortorici MA, Bowen JE, Dellota EA Jr, Dillen JR, Czudnochowski N, Pertusini L, Terrot T, Lepori V, Tarkowski M, Riva A, Biggiogero M, Pellanda AF, Garzoni C, Ferrari P, Ceschi A, Giannini O, Havenar-Daughton C, Telenti A, Arvin A, Virgin HW, Sallusto F, Veesler D, Lanzavecchia A, Corti D, Piccoli L. Marzi R, et al. Among authors: terrot t. bioRxiv [Preprint]. 2022 Sep 30:2022.09.30.509852. doi: 10.1101/2022.09.30.509852. bioRxiv. 2022. PMID: 36203553 Free PMC article. Updated. Preprint.
Physical activity and brain health in patients with atrial fibrillation.
Herber E, Aeschbacher S, Coslovsky M, Schwendinger F, Hennings E, Gasser A, Di Valentino M, Rigamonti E, Reichlin T, Rodondi N, Netzer S, Beer JH, Stauber A, Müller A, Ammann P, Sinnecker T, Duering M, Wuerfel J, Conen D, Kühne M, Osswald S, Bonati LH; SWISS-AF Investigators. Herber E, et al. Eur J Neurol. 2023 Mar;30(3):567-577. doi: 10.1111/ene.15660. Epub 2022 Dec 28. Eur J Neurol. 2023. PMID: 36478335 Free article.
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
Bassi J, Giannini O, Silacci-Fregni C, Pertusini L, Hitz P, Terrot T, Franzosi Y, Muoio F, Saliba C, Meury M, Dellota EA Jr, Dillen JR, Hernandez P, Czudnochowski N, Cameroni E, Beria N, Ventresca M, Badellino A, Lavorato-Hadjeres S, Lecchi E, Bonora T, Mattiolo M, Trinci G, Garzoni D, Bonforte G, Forni-Ogna V, Giunzioni D, Berwert L, Gupta RK, Ferrari P, Ceschi A, Cippà P, Corti D, Lanzavecchia A, Piccoli L. Bassi J, et al. Among authors: terrot t. PLoS One. 2022 Feb 10;17(2):e0263328. doi: 10.1371/journal.pone.0263328. eCollection 2022. PLoS One. 2022. PMID: 35143540 Free PMC article.
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas.
Pirosa MC, Zhang L, Hitz F, Novak U, Hess D, Terrot T, Pascale M, Mazzucchelli L, Bertoni F, Cavalli F, Zucca E, Stathis A. Pirosa MC, et al. Among authors: terrot t. Leuk Lymphoma. 2022 Jan;63(1):117-123. doi: 10.1080/10428194.2021.1966780. Epub 2021 Aug 19. Leuk Lymphoma. 2022. PMID: 34407735 Clinical Trial.
Prevalence of SARS-CoV-2 infection and impact of vaccination in dialysis patients over two years of the pandemic.
Hitz P, Pagnamenta A, Pertusini L, Terrot T, Franzosi Y, Bassi J, Silacci-Fregni C, Gaia V, Martinetti G, Keller F, Berwert L, Ogna VF, Lavorato-Hadjeres S, Giunzioni D, D'Ermo A, Valnegri A, Ferrari P, Corti D, Ceschi A, Cippà P, Piccoli L, Giannini O. Hitz P, et al. Among authors: terrot t. J Nephrol. 2023 Dec;36(9):2665-2667. doi: 10.1007/s40620-023-01754-1. Epub 2023 Sep 13. J Nephrol. 2023. PMID: 37702913 Free PMC article. No abstract available.
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.
Marzi R, Bassi J, Silacci-Fregni C, Bartha I, Muoio F, Culap K, Sprugasci N, Lombardo G, Saliba C, Cameroni E, Cassotta A, Low JS, Walls AC, McCallum M, Tortorici MA, Bowen JE, Dellota EA Jr, Dillen JR, Czudnochowski N, Pertusini L, Terrot T, Lepori V, Tarkowski M, Riva A, Biggiogero M, Franzetti-Pellanda A, Garzoni C, Ferrari P, Ceschi A, Giannini O, Havenar-Daughton C, Telenti A, Arvin A, Virgin HW, Sallusto F, Veesler D, Lanzavecchia A, Corti D, Piccoli L. Marzi R, et al. Among authors: terrot t. iScience. 2023 Jan 20;26(1):105726. doi: 10.1016/j.isci.2022.105726. Epub 2022 Dec 5. iScience. 2023. PMID: 36507220 Free PMC article.
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors.
Colombo I, Genta S, Martorana F, Guidi M, Frattini M, Samartzis EP, Brandt S, Gaggetta S, Moser L, Pascale M, Terrot T, Sessa C, Stathis A. Colombo I, et al. Among authors: terrot t. Clin Cancer Res. 2021 Sep 15;27(18):5012-5019. doi: 10.1158/1078-0432.CCR-21-1402. Epub 2021 Jul 15. Clin Cancer Res. 2021. PMID: 34266890 Clinical Trial.
12 results